Supervised by:
Dr. Muhammad Shariat Ullah
Department of Management
University of Dhaka
Submitted By
MD. SHAIFUL HAQUE KHAN
ID: 3-14-27-076
Date of Submission
June 11, 2016
No of Companies: 231
Exports: 72 Countries
Pharma
Tk (Crore)
Market Share
Growth %
Square
1378
19.18
23.54
Incepta
650
9.05
32.17
Beximco
620
8.62
40.33
Opsonin
355
4.94
26.09
Eskayef
348
4.84
24.82
Pestel Analysis
Political Factors
Political Instability (Hartal,
Strikes etc)
Export-Import policy
Social Factors
Economic Factors
High GDP growth (6.2%)
Exchange rates
Labor cost
Technological Factors
Religion
Demographics features of
population
Environmental Factors
Climate change affects on
operation
The National Drug Policy
2005 states that the
pharmaceutical plants must
comply with disposal of waste
streams
Legal Factors
World Bank (2009) reports
Bangladesh is ranked 119 out
of 183 economies on ease of
doing business
Monitoring and supervisory
role of DDA (Director of Drug
Administration)
WHOs current Good
Manufacturing Practices
(GMP) should be strictly
followed
References:
http://dspace.bracu.ac.bd/bitstream/handle/10361/3263/10164036.pdf?
sequence=1
http://www.pharmabiz.com/ArticleDetails.aspx?aid=77989&sid=21
http://cispharma.blogspot.com/2015/04/bangladesh-pharmaceuticalindustry.html